|
1KN4
CATALYTIC ANTIBODY D2.3 COMPLEX
提交 2001-12-18
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 L
21–239(219 aa)
|
未记录
|
ZN ZINC ION × 7
PDE PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;PEG600, ZnSO4, Cacodylate, pH 7.00, VAPOR DIFFUSION, HANGING DROP
|
分辨率 1.90 Å
R-free 0.246
|
|
1KN4
CATALYTIC ANTIBODY D2.3 COMPLEX
提交 2001-12-18
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 L
21–239(219 aa)
|
未记录
|
ZN ZINC ION × 14
PDE PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;PEG600, ZnSO4, Cacodylate, pH 7.00, VAPOR DIFFUSION, HANGING DROP
|
分辨率 1.90 Å
R-free 0.246
|
|
1KN4
CATALYTIC ANTIBODY D2.3 COMPLEX
提交 2001-12-18
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 L
21–239(219 aa)
|
未记录
|
ZN ZINC ION × 14
PDE PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;PEG600, ZnSO4, Cacodylate, pH 7.00, VAPOR DIFFUSION, HANGING DROP
|
分辨率 1.90 Å
R-free 0.246
|
|
1KN4
CATALYTIC ANTIBODY D2.3 COMPLEX
提交 2001-12-18
|
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 4
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 L
21–239(219 aa)
|
未记录
|
ZN ZINC ION × 7
PDE PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, HANGING DROP;pH 7;PEG600, ZnSO4, Cacodylate, pH 7.00, VAPOR DIFFUSION, HANGING DROP
|
分辨率 1.90 Å
R-free 0.246
|
|
1ND0
CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
提交 2002-12-05
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 A
21–239(219 aa)
片段:IMMUNOGLOBULIN FAB FRAGMENT, light chain
链 C
21–239(219 aa)
片段:IMMUNOGLOBULIN FAB FRAGMENT, light chain
|
未记录
|
DP4 (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;pH 5.5;295 K;ammonium sulfate, dioxane, tri-sodium citrate dihydrate, pH 5.5, evaporation, temperature 295K
|
分辨率 2.45 Å
R-free 0.286
|
|
1ND0
CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
提交 2002-12-05
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 2
蛋白异源复合物
异源复合物;蛋白 × 4
PDB 声明:tetrameric
|
链 E
21–239(219 aa)
片段:IMMUNOGLOBULIN FAB FRAGMENT, light chain
链 G
21–239(219 aa)
片段:IMMUNOGLOBULIN FAB FRAGMENT, light chain
|
未记录
|
DP4 (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;pH 5.5;295 K;ammonium sulfate, dioxane, tri-sodium citrate dihydrate, pH 5.5, evaporation, temperature 295K
|
分辨率 2.45 Å
R-free 0.286
|
|
1ND0
CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
提交 2002-12-05
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 3
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 A
21–239(219 aa)
片段:IMMUNOGLOBULIN FAB FRAGMENT, light chain
|
未记录
|
DP4 (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;pH 5.5;295 K;ammonium sulfate, dioxane, tri-sodium citrate dihydrate, pH 5.5, evaporation, temperature 295K
|
分辨率 2.45 Å
R-free 0.286
|
|
1ND0
CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
提交 2002-12-05
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 4
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 C
21–239(219 aa)
片段:IMMUNOGLOBULIN FAB FRAGMENT, light chain
|
未记录
|
DP4 (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;pH 5.5;295 K;ammonium sulfate, dioxane, tri-sodium citrate dihydrate, pH 5.5, evaporation, temperature 295K
|
分辨率 2.45 Å
R-free 0.286
|
|
1ND0
CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
提交 2002-12-05
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 5
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 E
21–239(219 aa)
片段:IMMUNOGLOBULIN FAB FRAGMENT, light chain
|
未记录
|
DP4 (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;pH 5.5;295 K;ammonium sulfate, dioxane, tri-sodium citrate dihydrate, pH 5.5, evaporation, temperature 295K
|
分辨率 2.45 Å
R-free 0.286
|
|
1ND0
CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
提交 2002-12-05
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 6
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 G
21–239(219 aa)
片段:IMMUNOGLOBULIN FAB FRAGMENT, light chain
|
未记录
|
DP4 (1s,4s)-4-[dimethyl(phenyl)silyl]-1-methylpiperidine 1-oxide × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
EVAPORATION;pH 5.5;295 K;ammonium sulfate, dioxane, tri-sodium citrate dihydrate, pH 5.5, evaporation, temperature 295K
|
分辨率 2.45 Å
R-free 0.286
|
|
1RU9
Crystal Structure (A) of u.v.-irradiated cationic cyclization antibody 4C6 Fab at pH 4.6 with a data set collected in-house.
提交 2003-12-11
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 L
21–239(219 aa)
片段:fab
|
非标准单体:是(mmCIF未提供具体位点)
|
GOL GLYCEROL × 5
ACT ACETATE ION × 1
BEZ BENZOIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 4.6;295 K;0.1M sodium acetate, pH 4.6, 0.2 M ammonium acetate, 15% (w/v) PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
分辨率 2.50 Å
R-free 0.247
|
|
1RUA
Crystal structure (B) of u.v.-irradiated cationic cyclization antibody 4C6 fab at pH 4.6 with a data set collected at SSRL beamline 11-1.
提交 2003-12-11
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 L
21–239(219 aa)
片段:fab
|
非标准单体:是(mmCIF未提供具体位点)
|
ACT ACETATE ION × 1
GOL GLYCEROL × 3
BEZ BENZOIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 4.6;295 K;0.1M sodium acetate, 0.2 M ammonium acetate, 15% (w/v) PEG 4000, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
分辨率 1.75 Å
R-free 0.251
|
|
1RUK
Crystal structure (C) of native cationic cyclization antibody 4C6 fab at pH 4.6 with a data set collected at SSRL beamline 9-1
提交 2003-12-11
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 L
21–239(219 aa)
片段:fab
|
未记录
|
ACT ACETATE ION × 1
BEZ BENZOIC ACID × 1
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 4.6;295 K;0.1M sodium acetate, 0.2 M ammonium acetate, 15% (w/v) PEG 4000, pH 4.6, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
分辨率 1.40 Å
R-free 0.210
|
|
1RUL
Crystal Structure (D) of u.v.-irradiated cationic cyclization antibody 4C6 Fab at pH 5.6 with a data set collected at SSRL beamline 11-1.
提交 2003-12-11
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 L
21–239(219 aa)
片段:fab
|
非标准单体:是(mmCIF未提供具体位点)
|
ACT ACETATE ION × 1
GOL GLYCEROL × 4
BEZ BENZOIC ACID × 1
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 5.6;295 K;0.1 M tri-sodium citrate, 0.2M ammonium acetate, 15% (w/v) PEG 4000, pH 5.6, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
分辨率 1.88 Å
R-free 0.283
|
|
1RUM
Crystal structure (F) of H2O2-soaked cationic cyclization antibody 4C6 fab at pH 8.5 with a data set collected at SSRL beamline 9-1.
提交 2003-12-11
|
构建体不同
突变/修饰不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 L
21–239(219 aa)
片段:fab
|
非标准单体:是(mmCIF未提供具体位点)
|
BEZ BENZOIC ACID × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;0.1 M tris hydrochloride, pH 8.5, 0.2 M sodium acetate, 15% (w/v) PEG 4000, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
分辨率 1.48 Å
R-free 0.245
|
|
1RUP
Crystal structure (G) of native cationic cyclization antibody 4C6 fab at pH 8.5 with a data set collected at APS beamline 19-ID
提交 2003-12-11
|
构建体不同
配体/离子不同
实验环境不同
结构质量不同
|
Assembly 1
蛋白异源复合物
异源复合物;蛋白 × 2
PDB 声明:dimeric
|
链 L
21–239(219 aa)
片段:fab
|
未记录
|
BEZ BENZOIC ACID × 1
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray结晶条件
VAPOR DIFFUSION, SITTING DROP;pH 8.5;295 K;0.1 M tris hydrochloride, 0.2 M sodium acetate, 15% (w/v) PEG 4000 , pH 8.5, VAPOR DIFFUSION, SITTING DROP, temperature 295K
|
分辨率 1.40 Å
R-free 0.212
|